Regional biotech on the world map
The Australian-New Zealand Biotech Alliance (ANZBA), in partnership with Invest Australia, has launched a web-based directory to promote the fast-growing regional biotechnology industry to the global market.
The directory will help global companies access local companies engaged in the pharmaceutical and biotechnology industries.
The Minister for Innovation, John Brumby, said it would ensure a broader knowledge of the region's biotech capabilities.
"Australia and New Zealand both offer a world-class, competitive location for conducting clinical trials and world-leading research," Brumby said.
The directory will include more than 700 participants, ranging from pre-clinical services to clinical trial stock manufacturers, along with a disease and demographic overview of the two countries.
Recent figures show that Australia and New Zealand provide 2% of global medical research publication output and 3% of world pharmaceutical sales, but only 1% of early pharmaceutical and biotech development.
The online directory is available at www.biotechalliance.org.
Govt announces $158m in funding for three new CRCs
Minister for Industry and Science Ed Husic has allocated $158 million to three new Cooperative...
Why are young plants more vulnerable to disease?
Fighting disease at a young age often comes at a steep cost to plants' growth and future...
Liquid catalyst could transform chemical manufacturing
A major breakthrough in liquid catalysis is transforming how essential products are made, making...
